Bayer HealthCare AG
Bayer HealthCare AG, a prominent subsidiary of Bayer AG, is headquartered in Leverkusen, Germany. Established in 1863, the company has evolved into a global leader in the pharmaceutical and life sciences industry, with significant operations across Europe, North America, and Asia. Bayer HealthCare focuses on key business areas such as prescription pharmaceuticals, consumer health products, and animal health, offering innovative solutions that address critical health challenges. Its core products, including advanced therapies in oncology, cardiology, and women's health, are distinguished by their commitment to research and development. With a strong market position, Bayer HealthCare has achieved numerous accolades for its contributions to healthcare, consistently prioritising patient needs and scientific excellence. The company's dedication to innovation and quality continues to set it apart in a competitive landscape.
DitchCarbon Score
How does Bayer HealthCare AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bayer HealthCare AG's score of 29 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bayer HealthCare AG's reported carbon emissions
In 2023, Bayer HealthCare AG reported total carbon emissions of approximately 10,080,000,000 kg CO2e, comprising 1,890,000,000 kg CO2e from Scope 1, 1,110,000,000 kg CO2e from Scope 2, and 9,180,000,000 kg CO2e from Scope 3 emissions. This represents a slight decrease in Scope 1 and Scope 2 emissions compared to 2022, where emissions were 1,910,000,000 kg CO2e and 1,120,000,000 kg CO2e, respectively. However, Scope 3 emissions also decreased from 9,720,000,000 kg CO2e in 2022. Bayer has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company continues to focus on sustainability and reducing its carbon footprint, although detailed commitments or strategies have not been specified. The emissions data indicates a commitment to monitoring and potentially reducing greenhouse gas emissions across all scopes, aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 1,910,000,000 | 0,000,000,000 |
| Scope 2 | 1,120,000,000 | 0,000,000,000 |
| Scope 3 | 9,720,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bayer HealthCare AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
